Market Research Logo

Onconova Therapeutics, Inc. - Product Pipeline Review - 2015

Onconova Therapeutics, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Onconova Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Onconova Therapeutics, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Onconova Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Onconova Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Onconova Therapeutics, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Onconova Therapeutics, Inc.’s pipeline products
Reasons to buy
  • Evaluate Onconova Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Onconova Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Onconova Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Onconova Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Onconova Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Onconova Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Onconova Therapeutics, Inc. Snapshot
Onconova Therapeutics, Inc. Overview
Key Information
Key Facts
Onconova Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Onconova Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Onconova Therapeutics, Inc. - Pipeline Products Glance
Onconova Therapeutics, Inc. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Onconova Therapeutics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Onconova Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Onconova Therapeutics, Inc. - Drug Profiles
rigosertib sodium
Product Description
Mechanism of Action
R&D Progress
briciclib sodium
Product Description
Mechanism of Action
R&D Progress
recilisib sodium
Product Description
Mechanism of Action
R&D Progress
ON-015640
Product Description
Mechanism of Action
R&D Progress
ON-108600
Product Description
Mechanism of Action
R&D Progress
ON-1231320
Product Description
Mechanism of Action
R&D Progress
ON-123300
Product Description
Mechanism of Action
R&D Progress
ON-146040
Product Description
Mechanism of Action
R&D Progress
ON-24 Series
Product Description
Mechanism of Action
R&D Progress
ON-24160
Product Description
Mechanism of Action
R&D Progress
ON-108110
Product Description
Mechanism of Action
R&D Progress
ON-128060
Product Description
Mechanism of Action
R&D Progress
Onconova Therapeutics, Inc. - Pipeline Analysis
Onconova Therapeutics, Inc. - Pipeline Products by Target
Onconova Therapeutics, Inc. - Pipeline Products by Route of Administration
Onconova Therapeutics, Inc. - Pipeline Products by Molecule Type
Onconova Therapeutics, Inc. - Pipeline Products by Mechanism of Action
Onconova Therapeutics, Inc. - Recent Pipeline Updates
Onconova Therapeutics, Inc. - Dormant Projects
Onconova Therapeutics, Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
rigosertib sodium
Onconova Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Onconova Therapeutics, Inc., Key Information
Onconova Therapeutics, Inc., Key Facts
Onconova Therapeutics, Inc. - Pipeline by Indication, 2015
Onconova Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Onconova Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Onconova Therapeutics, Inc. - Phase III, 2015
Onconova Therapeutics, Inc. - Phase II, 2015
Onconova Therapeutics, Inc. - Phase I, 2015
Onconova Therapeutics, Inc. - Preclinical, 2015
Onconova Therapeutics, Inc. - Discovery, 2015
Onconova Therapeutics, Inc. - Pipeline by Target, 2015
Onconova Therapeutics, Inc. - Pipeline by Route of Administration, 2015
Onconova Therapeutics, Inc. - Pipeline by Molecule Type, 2015
Onconova Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015
Onconova Therapeutics, Inc. - Recent Pipeline Updates, 2015
Onconova Therapeutics, Inc. - Dormant Developmental Projects,2015
Onconova Therapeutics, Inc. - Discontinued Pipeline Products, 2015
Onconova Therapeutics, Inc., Other Locations
List of Figures
Onconova Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
Onconova Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Onconova Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Onconova Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
Onconova Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
Onconova Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
Onconova Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report